article_snippet.sent: Thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination, claim researchers.
article_snippet.sent: Cancer that has spread and is incurable, known as secondary breast cancer, kills 1,000 women in Britain every month.
article_snippet.sent: Thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination.
article_snippet.sent: However, many women go on to develop resistance and the disease comes back, often because cancer stem cells which cause tumours to regrow and spread are unaffected by these treatments.
article_snippet.sent: ’ Katie Goates, at Breakthrough Breast Cancer and Breast Cancer Campaign, said:
article_snippet.sent: This means that the combination also has the potential to extend how long tamoxifen treatment can work for women with secondary breast cancer (cancer that has spread), the incurable form of the disease.
article_snippet.sent: ‘Secondary breast cancer still kills 1,000 women in the UK every month so research that helps us to discover improved treatment options for women living with this form of breast cancer, or to help prevent cancer spreading, are vitally important.
highlights_snippet.sent: cause tumours to re-grow, causing secondary breast cancer .
  